Clinical Trial Update: Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating midostaurin with standard chemotherapy for core-binding factor acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Midostaurin (midostaurin)

Snippet

Sponsor: Niguarda Hospital | Conditions: Core Binding Factor Acute Myeloid Leukemia (CBF-AML) | Phase 2 | Status: TERMINATED